Ellen Agler

CEO, The END Fund

Ellen is the Chief Executive Officer of the END Fund. Previously, she served as Operation Smile’s Senior Vice President for International Programs, managing programs to provide comprehensive care to children with cleft lips and cleft palates in over 60 countries in Latin America, the Middle East, Africa and Asia. She also led Operation Smile’s global public policy, collaboration and advocacy efforts to promote essential surgery as an integral component of global health policy and programming. Ellen holds graduate degrees in International Health from the Harvard School of Public Health, with a focus on humanitarian affairs, and in Development Studies from the London School of Economics, with a focus on non-profit management and child rights. She has also done postgraduate studies in Conflict Resolution at Universidad de Javeriana in Bogota, Colombia.

Awa Marie Coll Seck

Minister of Health and Social Action, Republic of Senegal

Awa Marie Coll Seck has served as Minister of Health of the Republic of Senegal since 2012. She was Executive Director of the Roll Back Malaria Partnership (RMB) from 2004-2011 and served as Director of the UNAIDS Department of Country and Regional Support from 1996-2001. She was Minister of Health and Prevention of Senegal from 2001 to 2003. Dr Coll Seck was elected as chairperson of Committee B of the World Health Assembly and as president of the Assembly of the Ministries of Health of the West African Health Organization in 2002. She has been awarded numerous professional and academic honours, including the Knight of the Order of Merit of the French Republic, Chevalier, Ordre des Palmes académiques; Officer of the Order of Merit Senegalese; and Knight of the Order of Merit of Burkina Faso. She is an honorary member of the Academy of Sciences and Technologies of Senegal and is the author of more than 150 scientific publications. Dr Coll Seck earned her medical degree from the University of Dakar in 1978.

Peter McDermott

Director, Fajara Associates

Peter is the Director of Fajara Associates, and is an internationally renowned development expert with over 25 years’ experience in the design and successful delivery of global initiatives for women and children living in poverty, affected by disease and impacted by conflict. A mission-driven leader, with extensive international experience including under the most difficult circumstances. Over ten years’ experience as a Board member/trustee with executive leadership in philanthropy. Strong diplomatic skills and a track record developing strategic partnerships and a proven ability to convene, persuade and facilitate the building of consensus among diverse groups and individuals. At ease working with heads of states, executive leadership of international organizations as well as community leaders. In collaboration with the co-founders, shaped one of the UK’s largest foundations into an increasingly strategic and effective organization with a growing reputation for rigor and results for children and women.

Peter Small

Jim and Robin Hernstein Chair, Founding Director, Global Health Institute, Stony Brook University

Peter is the Jim and Robin Herrnstein Chair and the Founding Director, Global Health Institute at Stony Brook University. Prior to joining Stony Brook, Peter was at the Bill and Melinda Gates Foundation for nearly 13 years where he was responsible for developing the foundation’s tuberculosis strategy, building the programs core partnerships, hiring and managing the TB team and serving as the foundation’s voice for tuberculosis. In 2011, he relocated to India where he established the foundation’s tuberculosis program in India, specifically focused on the ways in which innovation in tuberculosis delivery systems might accelerate the decline of tuberculosis incidence. Peter completed his post graduate training in internal medicine at UCSF and infectious diseases at Stanford University before spending about a decade on the faculty of Stanford’s Division of Infectious Disease and Geographic Medicine. Peter has published more than 150 articles including studies that helped to shape the public health response to the resurgence of tuberculosis in the USA in the 1990’s and seminal papers on theorigin, nature and consequence of genetic variability within the species M. tuberculosis. He is a recipient of the Princess Chichibu Global TB Award for his pioneering contributions to global tuberculosis control and a fellow in the American Academy of Microbiology.

We look forward to hearing from you.